Global Quetiapine Fumarate Market Research Report 2023(Status and Outlook)
Report Overview
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
The Global Quetiapine Fumarate Market Size was estimated at USD 163.30 million in 2022 and is projected to reach USD 139.75 million by 2029, exhibiting a CAGR of -2.20% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Quetiapine Fumarate market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Quetiapine Fumarate Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Quetiapine Fumarate market in any manner.
Global Quetiapine Fumarate Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Market Segmentation (by Type)
Immediate Release Tablets
Extended Release Tablets
Market Segmentation (by Application)
Chemical
Petrochemical and Oil & Gas
HVACR, Food & Beverage
Power Generation
Paper & pulp
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Quetiapine Fumarate Market
Overview of the regional outlook of the Quetiapine Fumarate Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Quetiapine Fumarate
- 1.2 Key Market Segments
- 1.2.1 Quetiapine Fumarate Segment by Type
- 1.2.2 Quetiapine Fumarate Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Quetiapine Fumarate Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Quetiapine Fumarate Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Quetiapine Fumarate Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Quetiapine Fumarate Market Competitive Landscape
- 3.1 Global Quetiapine Fumarate Sales by Manufacturers (2018-2023)
- 3.2 Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Quetiapine Fumarate Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Quetiapine Fumarate Sales Sites, Area Served, Product Type
- 3.6 Quetiapine Fumarate Market Competitive Situation and Trends
- 3.6.1 Quetiapine Fumarate Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Quetiapine Fumarate Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Quetiapine Fumarate Industry Chain Analysis
- 4.1 Quetiapine Fumarate Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Quetiapine Fumarate Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Quetiapine Fumarate Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Quetiapine Fumarate Sales Market Share by Type (2018-2023)
- 6.3 Global Quetiapine Fumarate Market Size Market Share by Type (2018-2023)
- 6.4 Global Quetiapine Fumarate Price by Type (2018-2023)
- 7 Quetiapine Fumarate Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Quetiapine Fumarate Market Sales by Application (2018-2023)
- 7.3 Global Quetiapine Fumarate Market Size (M USD) by Application (2018-2023)
- 7.4 Global Quetiapine Fumarate Sales Growth Rate by Application (2018-2023)
- 8 Quetiapine Fumarate Market Segmentation by Region
- 8.1 Global Quetiapine Fumarate Sales by Region
- 8.1.1 Global Quetiapine Fumarate Sales by Region
- 8.1.2 Global Quetiapine Fumarate Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Quetiapine Fumarate Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Quetiapine Fumarate Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Quetiapine Fumarate Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Quetiapine Fumarate Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Quetiapine Fumarate Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 AstraZeneca
- 9.1.1 AstraZeneca Quetiapine Fumarate Basic Information
- 9.1.2 AstraZeneca Quetiapine Fumarate Product Overview
- 9.1.3 AstraZeneca Quetiapine Fumarate Product Market Performance
- 9.1.4 AstraZeneca Business Overview
- 9.1.5 AstraZeneca Quetiapine Fumarate SWOT Analysis
- 9.1.6 AstraZeneca Recent Developments
- 9.2 Intas
- 9.2.1 Intas Quetiapine Fumarate Basic Information
- 9.2.2 Intas Quetiapine Fumarate Product Overview
- 9.2.3 Intas Quetiapine Fumarate Product Market Performance
- 9.2.4 Intas Business Overview
- 9.2.5 Intas Quetiapine Fumarate SWOT Analysis
- 9.2.6 Intas Recent Developments
- 9.3 TAPI
- 9.3.1 TAPI Quetiapine Fumarate Basic Information
- 9.3.2 TAPI Quetiapine Fumarate Product Overview
- 9.3.3 TAPI Quetiapine Fumarate Product Market Performance
- 9.3.4 TAPI Business Overview
- 9.3.5 TAPI Quetiapine Fumarate SWOT Analysis
- 9.3.6 TAPI Recent Developments
- 9.4 Accord
- 9.4.1 Accord Quetiapine Fumarate Basic Information
- 9.4.2 Accord Quetiapine Fumarate Product Overview
- 9.4.3 Accord Quetiapine Fumarate Product Market Performance
- 9.4.4 Accord Business Overview
- 9.4.5 Accord Quetiapine Fumarate SWOT Analysis
- 9.4.6 Accord Recent Developments
- 9.5 Hexal
- 9.5.1 Hexal Quetiapine Fumarate Basic Information
- 9.5.2 Hexal Quetiapine Fumarate Product Overview
- 9.5.3 Hexal Quetiapine Fumarate Product Market Performance
- 9.5.4 Hexal Business Overview
- 9.5.5 Hexal Quetiapine Fumarate SWOT Analysis
- 9.5.6 Hexal Recent Developments
- 9.6 Dr.Reddy's
- 9.6.1 Dr.Reddy's Quetiapine Fumarate Basic Information
- 9.6.2 Dr.Reddy's Quetiapine Fumarate Product Overview
- 9.6.3 Dr.Reddy's Quetiapine Fumarate Product Market Performance
- 9.6.4 Dr.Reddy's Business Overview
- 9.6.5 Dr.Reddy's Recent Developments
- 9.7 Lupin
- 9.7.1 Lupin Quetiapine Fumarate Basic Information
- 9.7.2 Lupin Quetiapine Fumarate Product Overview
- 9.7.3 Lupin Quetiapine Fumarate Product Market Performance
- 9.7.4 Lupin Business Overview
- 9.7.5 Lupin Recent Developments
- 9.8 Sun Pharmaceutical
- 9.8.1 Sun Pharmaceutical Quetiapine Fumarate Basic Information
- 9.8.2 Sun Pharmaceutical Quetiapine Fumarate Product Overview
- 9.8.3 Sun Pharmaceutical Quetiapine Fumarate Product Market Performance
- 9.8.4 Sun Pharmaceutical Business Overview
- 9.8.5 Sun Pharmaceutical Recent Developments
- 9.9 Hunan Dongting Pharm
- 9.9.1 Hunan Dongting Pharm Quetiapine Fumarate Basic Information
- 9.9.2 Hunan Dongting Pharm Quetiapine Fumarate Product Overview
- 9.9.3 Hunan Dongting Pharm Quetiapine Fumarate Product Market Performance
- 9.9.4 Hunan Dongting Pharm Business Overview
- 9.9.5 Hunan Dongting Pharm Recent Developments
- 9.10 SuZhou NO.4 Phamaceutical Factory
- 9.10.1 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Basic Information
- 9.10.2 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Overview
- 9.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Market Performance
- 9.10.4 SuZhou NO.4 Phamaceutical Factory Business Overview
- 9.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments
- 9.11 Fuan Pharmaceutical
- 9.11.1 Fuan Pharmaceutical Quetiapine Fumarate Basic Information
- 9.11.2 Fuan Pharmaceutical Quetiapine Fumarate Product Overview
- 9.11.3 Fuan Pharmaceutical Quetiapine Fumarate Product Market Performance
- 9.11.4 Fuan Pharmaceutical Business Overview
- 9.11.5 Fuan Pharmaceutical Recent Developments
- 9.12 Zhejiang Supor Pharmaceuticals
- 9.12.1 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Basic Information
- 9.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Overview
- 9.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Market Performance
- 9.12.4 Zhejiang Supor Pharmaceuticals Business Overview
- 9.12.5 Zhejiang Supor Pharmaceuticals Recent Developments
- 9.13 Zhejiang Huahai Pharmaceutical
- 9.13.1 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Basic Information
- 9.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Overview
- 9.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Market Performance
- 9.13.4 Zhejiang Huahai Pharmaceutical Business Overview
- 9.13.5 Zhejiang Huahai Pharmaceutical Recent Developments
- 10 Quetiapine Fumarate Market Forecast by Region
- 10.1 Global Quetiapine Fumarate Market Size Forecast
- 10.2 Global Quetiapine Fumarate Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Quetiapine Fumarate Market Size Forecast by Country
- 10.2.3 Asia Pacific Quetiapine Fumarate Market Size Forecast by Region
- 10.2.4 South America Quetiapine Fumarate Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Quetiapine Fumarate by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Quetiapine Fumarate Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Quetiapine Fumarate by Type (2024-2029)
- 11.1.2 Global Quetiapine Fumarate Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Quetiapine Fumarate by Type (2024-2029)
- 11.2 Global Quetiapine Fumarate Market Forecast by Application (2024-2029)
- 11.2.1 Global Quetiapine Fumarate Sales (K MT) Forecast by Application
- 11.2.2 Global Quetiapine Fumarate Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook